BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33690246)

  • 1. The Microbiome and Metabolome of Malignant Fungating Wounds: A Systematic Review of the Literature From 1995 to 2020.
    Tilley CP; Fu MR; Qiu JM; Comfort C; Crocilla BL; Li Z; Axelrod D
    J Wound Ostomy Continence Nurs; 2021 Mar-Apr 01; 48(2):124-135. PubMed ID: 33690246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptoms of Malignant Fungating Wounds and Functional Performance among Patients with Advanced Cancer: An Integrative Review from 2000 to 2019.
    Tilley CP; Fu MR; Van Cleeve J; Crocilla BL; Comfort CP
    J Palliat Med; 2020 Jun; 23(6):848-862. PubMed ID: 32349622
    [No Abstract]   [Full Text] [Related]  

  • 3. [The physical, psychological, social, and spiritual impacts of malignant fungating wounds on cancer patients].
    Lo SF; Hu WY
    Hu Li Za Zhi; 2008 Feb; 55(1):75-80. PubMed ID: 18270936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palliative Wound Care for Malignant Fungating Wounds: Holistic Considerations at End-of-Life.
    Tilley C; Lipson J; Ramos M
    Nurs Clin North Am; 2016 Sep; 51(3):513-31. PubMed ID: 27497023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Microbiome, Malignant Fungating Wounds, and Palliative Care.
    Vardhan M; Flaminio Z; Sapru S; Tilley CP; Fu MR; Comfort C; Li X; Saxena D
    Front Cell Infect Microbiol; 2019; 9():373. PubMed ID: 31737576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caring for Patients With Malignant Fungating Wounds: A Scoping Literature Review.
    Yasmara D; Tam SH; Fang SY
    J Wound Ostomy Continence Nurs; 2024 Jan-Feb 01; 51(1):19-25. PubMed ID: 38215293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of topical treatments to control the odor of malignant fungating wounds.
    da Costa Santos CM; de Mattos Pimenta CA; Nobre MR
    J Pain Symptom Manage; 2010 Jun; 39(6):1065-76. PubMed ID: 20538188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Components of Exudates and Periwound Moisture-Associated Dermatitis in Breast Cancer Patients With Malignant Fungating Wounds.
    Tamai N; Akase T; Minematsu T; Higashi K; Toida T; Igarashi K; Sanada H
    Biol Res Nurs; 2016 Mar; 18(2):199-206. PubMed ID: 26180182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INSTRUCTIONS: The Microbiome and Metabolome of Malignant Fungating Wounds: A Systematic Review of the Literature From 1995 to 2020.
    J Wound Ostomy Continence Nurs; 2021 Mar-Apr 01; 48(2):E2. PubMed ID: 33690247
    [No Abstract]   [Full Text] [Related]  

  • 10. Topical agents and dressings for fungating wounds.
    Adderley U; Smith R
    Cochrane Database Syst Rev; 2007 Apr; (2):CD003948. PubMed ID: 17443534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment and management of fungating wounds: a review.
    Wilson V
    Br J Community Nurs; 2005 Mar; 10(3):S28-34. PubMed ID: 15824709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical agents and dressings for fungating wounds.
    Adderley UJ; Holt IG
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD003948. PubMed ID: 24832784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intervention for symptom management in patients with malignant fungating wounds - a systematic review.
    Tsichlakidou A; Govina O; Vasilopoulos G; Kavga A; Vastardi M; Kalemikerakis I
    J BUON; 2019; 24(3):1301-1308. PubMed ID: 31424694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical therapy for pain management in malignant fungating wounds: A scoping review.
    da Costa Ferreira SA; Serna González CV; Thum M; da Costa Faresin AA; Woo K; de Gouveia Santos VLC
    J Clin Nurs; 2023 Jul; 32(13-14):3015-3029. PubMed ID: 36055976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant fungating wounds: key symptoms and psychosocial issues.
    Alexander S
    J Wound Care; 2009 Aug; 18(8):325-9. PubMed ID: 19862870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coping with an exulcerated breast carcinoma: an interpretative phenomenological study.
    Probst S; Arber A; Faithfull S
    J Wound Care; 2013 Jul; 22(7):352-4, 356-8, 360. PubMed ID: 24159657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The palliative management of fungating malignant wounds.
    Grocott P
    J Wound Care; 2000 Jan; 9(1):4-9. PubMed ID: 10827661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of malodour and exudate in fungating wounds.
    Draper C
    Br J Nurs; 2005 Jun 9-22; 14(11):S4-12. PubMed ID: 15976610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of malignant fungating wounds in advanced cancer.
    Seaman S
    Semin Oncol Nurs; 2006 Aug; 22(3):185-93. PubMed ID: 16893748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.